Comedy stars unite for ‘Shake with Laughter’

Perspectives

Author: Joe McAweaneyPublished: 11 October 2017

Prep: Cook: Serves:

‘Shake with Laughter’ – a Parkinson’s comedy fundraiser featuring Rob Deering and Tim Vine – will be performed at London’s iconic Comedy Store on 16 October

On 16 October The Comedy Store, London, UK, will play host to the sixth edition of the Parkinson’s fundraiser ‘Shake with Laughter’.

The annual comedy show, from which all proceeds go to charity Parkinson’s UK, will feature comedians including Rob Deering, Gary Delaney, Lucy Porter, Paul Mayhew-Archer and Tim Vine.

‘Shake with Laughter’ launched in London in 2012 and has since been held in Manchester and Newcastle, with plans to debut in Glasgow next month.

Rob Deering, whose father has Parkinson’s, is a longstanding fundraiser for Parkinson’s UK. The popular stand-up has participated in marathons, comedy events and celebrity quiz shows including Pointless and The Weakest Link. He is currently on track to reach his £100,000 fundraising target over 10 years.

For more information about the event and the comedians taking part, you can visit the Parkinson’s UK website here.

Read more: October 2017 events

Diana Levine: taking photos for a cure

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Emma Lawton on her new “bucket list” project

We spoke to Parkinson’s activist Emma Lawton

Parkinson’s Life 2018 highlights

We look back at some of our favourite stories from 2018

Frozen faces: 15 icy images that show what it’s like to lose control of your expressions

Unmasking the emotions of Parkinson’s

Scientists at MIT uncover new clues about Parkinson’s disease

Neuroscientists at Massachusetts Institute of Technology (MIT), US, have developed new tools that could improve understanding of Parkinson’s disease. As part of a study, published in Science Advances, the tools were used on animals to investigate the relationship between two types of signals that are disrupted in Parkinson’s – dopamine signalling and beta-band oscillations (coordinated waves of electrical activity in the brain). The scientists found that while the animals performed certain tasks, beta-band oscillations increased while dopamine signalling declined in particular parts of the brain. Factors including an animal’s past experience and the reward value of a task also impacted the relationship between the two signals. Helen Schwerdt, a research scientist at MIT, said: “Considering electrical signals side by side with chemical signals is really important to understand how the brain works.” Ann Graybiel, a professor at MIT, added: “As these methods in neuroscience become more and more precise and…

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

A new database study of around 80,000 Covid-19 patients has found that those living with Parkinson’s disease have a 30% higher risk of dying from the virus than those without the condition. The study – conducted by researchers at the University of Iowa Health Care, US – identified that Covid-19 patients with Parkinson’s disease were generally older, more likely to be male and less likely to be African American. As these factors could also affect the risk of death from Covid-19, the researchers adjusted their statistical models to account for differences in sex, age and race and found a significantly higher risk of dying from Covid-19 in the group of patients with Parkinson’s disease. Lead researcher Dr Nandakumar Narayanan said: “We recognise the limitations of this study; it is retrospective data from a single database, but we are confident that these data show that Parkinson’s disease is [an] independent risk factor…

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

Portugal-based pharmaceutical company BIAL has launched a new research centre, BIAL Biotech, in Massachusetts, US, which will focus on genetically defined Parkinson’s disease. BIAL has also announced that it has acquired the Parkinson’s disease research programmes of Lysosomal Therapeutics Inc, as well as its research and development team and clinical programme for LTI-291 – a therapy designed to treat a genetic form of the condition. António Portela, executive president of BIAL, said: “Our entry into the US with the creation of BIAL Biotech and the acquisition of the promising programmes from LTI, is a decisive step towards the fulfilment of our mission to contribute to improving the quality of life of people worldwide. “The development of this new research centre in the US, is a landmark of enormous relevance for us. We are investing in science and research, through our direct presence in one of the most important research hubs…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Comedy stars unite for ‘Shake with Laughter’

Perspectives

Author: Joe McAweaneyPublished: 11 October 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Emma Lawton on her new “bucket list” project

Perspectives

Parkinson’s Life 2018 highlights

Interviews

Frozen faces: 15 icy images that show what it’s like to lose control of your expressions

Scientists at MIT uncover new clues about Parkinson’s disease

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

{title}

Subscribe

Comedy stars unite for ‘Shake with Laughter’

Perspectives

Author: Joe McAweaneyPublished: 11 October 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Emma Lawton on her new “bucket list” project

Perspectives

Parkinson’s Life 2018 highlights

Interviews

Frozen faces: 15 icy images that show what it’s like to lose control of your expressions

Scientists at MIT uncover new clues about Parkinson’s disease

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

{title}

Subscribe

Sign in